目次

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
Exhibit 06: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size
4.1 Global heparin market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on Global heparin market 2017 - 2021 ($ million)
4.2 Product Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Product Segment 2017 - 2021 ($ million)
4.3 Route of administration Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - Route of administration Segment 2017 - 2021 ($ million)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Product
6.1 Market segments
Exhibit 30: Chart on Product - Market share 2022-2027 (%)
Exhibit 31: Data Table on Product - Market share 2022-2027 (%)
6.2 Comparison by Product
Exhibit 32: Chart on Comparison by Product
Exhibit 33: Data Table on Comparison by Product
6.3 Low-molecular-weight heparin - Market size and forecast 2022-2027
Exhibit 34: Chart on Low-molecular-weight heparin - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on Low-molecular-weight heparin - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on Low-molecular-weight heparin - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Low-molecular-weight heparin - Year-over-year growth 2022-2027 (%)
6.4 Others - Market size and forecast 2022-2027
Exhibit 38: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Others - Year-over-year growth 2022-2027 (%)
6.5 Market opportunity by Product
Exhibit 42: Market opportunity by Product ($ million)

7 Market Segmentation by Route of Administration
7.1 Market segments
Exhibit 43: Chart on Route of Administration - Market share 2022-2027 (%)
Exhibit 44: Data Table on Route of Administration - Market share 2022-2027 (%)
7.2 Comparison by Route of Administration
Exhibit 45: Chart on Comparison by Route of Administration
Exhibit 46: Data Table on Comparison by Route of Administration
7.3 Subcutaneous injection - Market size and forecast 2022-2027
Exhibit 47: Chart on Subcutaneous injection - Market size and forecast 2022-2027 ($ million)
Exhibit 48: Data Table on Subcutaneous injection - Market size and forecast 2022-2027 ($ million)
Exhibit 49: Chart on Subcutaneous injection - Year-over-year growth 2022-2027 (%)
Exhibit 50: Data Table on Subcutaneous injection - Year-over-year growth 2022-2027 (%)
7.4 Intravenous/infusion - Market size and forecast 2022-2027
Exhibit 51: Chart on Intravenous/infusion - Market size and forecast 2022-2027 ($ million)
Exhibit 52: Data Table on Intravenous/infusion - Market size and forecast 2022-2027 ($ million)
Exhibit 53: Chart on Intravenous/infusion - Year-over-year growth 2022-2027 (%)
Exhibit 54: Data Table on Intravenous/infusion - Year-over-year growth 2022-2027 (%)
7.5 Market opportunity by Route of Administration
Exhibit 55: Market opportunity by Route of Administration ($ million)

8 Customer Landscape
8.1 Customer landscape overview
Exhibit 56: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 57: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 58: Data Table on Market share By Geographical Landscape 2022-2027 (%)
9.2 Geographic comparison
Exhibit 59: Chart on Geographic comparison
Exhibit 60: Data Table on Geographic comparison
9.3 Europe - Market size and forecast 2022-2027
Exhibit 61: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 62: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 63: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 64: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.4 North America - Market size and forecast 2022-2027
Exhibit 65: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 66: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 67: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 68: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 69: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 70: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 71: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 72: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 73: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 74: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 75: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 76: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 77: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 78: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 79: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 80: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 UK - Market size and forecast 2022-2027
Exhibit 81: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 82: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 83: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 84: Data Table on UK - Year-over-year growth 2022-2027 (%)
9.9 Germany - Market size and forecast 2022-2027
Exhibit 85: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 86: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 87: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 88: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.10 China - Market size and forecast 2022-2027
Exhibit 89: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibit 90: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibit 91: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 92: Data Table on China - Year-over-year growth 2022-2027 (%)
9.11 France - Market size and forecast 2022-2027
Exhibit 93: Chart on France - Market size and forecast 2022-2027 ($ million)
Exhibit 94: Data Table on France - Market size and forecast 2022-2027 ($ million)
Exhibit 95: Chart on France - Year-over-year growth 2022-2027 (%)
Exhibit 96: Data Table on France - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 97: Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 98: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends

11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 99: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 100: Overview on factors of disruption
11.4 Industry risks
Exhibit 101: Impact of key risks on business

12 Vendor Analysis
12.1 Vendors covered
Exhibit 102: Vendors covered
12.2 Market positioning of vendors
Exhibit 103: Matrix on vendor position and classification
12.3 Aspen Pharmacare Holdings
Exhibit 104: Aspen Pharmacare Holdings - Overview
Exhibit 105: Aspen Pharmacare Holdings - Business segments
Exhibit 106: Aspen Pharmacare Holdings - Key offerings
Exhibit 107: Aspen Pharmacare Holdings - Segment focus
12.4 B. Braun SE
Exhibit 108: B. Braun SE - Overview
Exhibit 109: B. Braun SE - Business segments
Exhibit 110: B. Braun SE - Key news
Exhibit 111: B. Braun SE - Key offerings
Exhibit 112: B. Braun SE - Segment focus
12.5 Baxter International Inc.
Exhibit 113: Baxter International Inc. - Overview
Exhibit 114: Baxter International Inc. - Business segments
Exhibit 115: Baxter International Inc. - Key news
Exhibit 116: Baxter International Inc. - Key offerings
Exhibit 117: Baxter International Inc. - Segment focus
12.6 Eisai Co. Ltd.
Exhibit 118: Eisai Co. Ltd. - Overview
Exhibit 119: Eisai Co. Ltd. - Business segments
Exhibit 120: Eisai Co. Ltd. - Key offerings
Exhibit 121: Eisai Co. Ltd. - Segment focus
12.7 Fresenius SE and Co. KGaA
Exhibit 122: Fresenius SE and Co. KGaA - Overview
Exhibit 123: Fresenius SE and Co. KGaA - Business segments
Exhibit 124: Fresenius SE and Co. KGaA - Key news
Exhibit 125: Fresenius SE and Co. KGaA - Key offerings
Exhibit 126: Fresenius SE and Co. KGaA - Segment focus
12.8 Hikma Pharmaceuticals Plc
Exhibit 127: Hikma Pharmaceuticals Plc - Overview
Exhibit 128: Hikma Pharmaceuticals Plc - Business segments
Exhibit 129: Hikma Pharmaceuticals Plc - Key offerings
Exhibit 130: Hikma Pharmaceuticals Plc - Segment focus
12.9 Laboratorios Farmaceuticos Rovi
Exhibit 131: Laboratorios Farmaceuticos Rovi - Overview
Exhibit 132: Laboratorios Farmaceuticos Rovi - Business segments
Exhibit 133: Laboratorios Farmaceuticos Rovi - Key offerings
Exhibit 134: Laboratorios Farmaceuticos Rovi - Segment focus
12.10 Nanjing Kingfriend Biochemical
Exhibit 135: Nanjing Kingfriend Biochemical - Overview
Exhibit 136: Nanjing Kingfriend Biochemical - Product / Service
Exhibit 137: Nanjing Kingfriend Biochemical - Key offerings
12.11 Nichi Iko Pharmaceutical Co. Ltd.
Exhibit 138: Nichi Iko Pharmaceutical Co. Ltd. - Overview
Exhibit 139: Nichi Iko Pharmaceutical Co. Ltd. - Product / Service
Exhibit 140: Nichi Iko Pharmaceutical Co. Ltd. - Key offerings
12.12 Novartis AG
Exhibit 141: Novartis AG - Overview
Exhibit 142: Novartis AG - Business segments
Exhibit 143: Novartis AG - Key offerings
Exhibit 144: Novartis AG - Segment focus
12.13 Pfizer Inc.
Exhibit 145: Pfizer Inc. - Overview
Exhibit 146: Pfizer Inc. - Product / Service
Exhibit 147: Pfizer Inc. - Key news
Exhibit 148: Pfizer Inc. - Key offerings
12.14 Sanofi SA
Exhibit 149: Sanofi SA - Overview
Exhibit 150: Sanofi SA - Business segments
Exhibit 151: Sanofi SA - Key news
Exhibit 152: Sanofi SA - Key offerings
Exhibit 153: Sanofi SA - Segment focus
12.15 Shenzhen Techdow Pharmaceutical
Exhibit 154: Shenzhen Techdow Pharmaceutical - Overview
Exhibit 155: Shenzhen Techdow Pharmaceutical - Product / Service
Exhibit 156: Shenzhen Techdow Pharmaceutical - Key offerings
12.16 Teva Pharmaceutical Industries Ltd.
Exhibit 157: Teva Pharmaceutical Industries Ltd. - Overview
Exhibit 158: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibit 159: Teva Pharmaceutical Industries Ltd. - Key news
Exhibit 160: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibit 161: Teva Pharmaceutical Industries Ltd. - Segment focus
12.17 Viatris Inc.
Exhibit 162: Viatris Inc. - Overview
Exhibit 163: Viatris Inc. - Business segments
Exhibit 164: Viatris Inc. - Key offerings
Exhibit 165: Viatris Inc. - Segment focus

13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 166: Inclusions checklist
Exhibit 167: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 168: Currency conversion rates for US$
13.4 Research methodology
Exhibit 169: Research methodology
Exhibit 170: Validation techniques employed for market sizing
Exhibit 171: Information sources
13.5 List of abbreviations
Exhibit 172: List of abbreviations

Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Product
Exhibits6: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on Global heparin market 2017 - 2021 ($ million)
Exhibits19: Historic Market Size - Product Segment 2017 - 2021 ($ million)
Exhibits20: Historic Market Size - Route of administration Segment 2017 - 2021 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits23: Five forces analysis - Comparison between2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on Product - Market share 2022-2027 (%)
Exhibits31: Data Table on Product - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Product
Exhibits33: Data Table on Comparison by Product
Exhibits34: Chart on Low-molecular-weight heparin - Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Low-molecular-weight heparin - Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Low-molecular-weight heparin - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Low-molecular-weight heparin - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Others - Year-over-year growth 2022-2027 (%)
Exhibits42: Market opportunity by Product ($ million)
Exhibits43: Chart on Route of Administration - Market share 2022-2027 (%)
Exhibits44: Data Table on Route of Administration - Market share 2022-2027 (%)
Exhibits45: Chart on Comparison by Route of Administration
Exhibits46: Data Table on Comparison by Route of Administration
Exhibits47: Chart on Subcutaneous injection - Market size and forecast 2022-2027 ($ million)
Exhibits48: Data Table on Subcutaneous injection - Market size and forecast 2022-2027 ($ million)
Exhibits49: Chart on Subcutaneous injection - Year-over-year growth 2022-2027 (%)
Exhibits50: Data Table on Subcutaneous injection - Year-over-year growth 2022-2027 (%)
Exhibits51: Chart on Intravenous/infusion - Market size and forecast 2022-2027 ($ million)
Exhibits52: Data Table on Intravenous/infusion - Market size and forecast 2022-2027 ($ million)
Exhibits53: Chart on Intravenous/infusion - Year-over-year growth 2022-2027 (%)
Exhibits54: Data Table on Intravenous/infusion - Year-over-year growth 2022-2027 (%)
Exhibits55: Market opportunity by Route of Administration ($ million)
Exhibits56: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits57: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits58: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits59: Chart on Geographic comparison
Exhibits60: Data Table on Geographic comparison
Exhibits61: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits62: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits63: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits64: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits65: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits66: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits67: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits68: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits69: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits70: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits71: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits72: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits73: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits74: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits75: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits76: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits77: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits78: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits79: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits80: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits81: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits82: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits83: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits84: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits85: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits86: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits87: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits88: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits89: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits90: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits91: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits92: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits93: Chart on France - Market size and forecast 2022-2027 ($ million)
Exhibits94: Data Table on France - Market size and forecast 2022-2027 ($ million)
Exhibits95: Chart on France - Year-over-year growth 2022-2027 (%)
Exhibits96: Data Table on France - Year-over-year growth 2022-2027 (%)
Exhibits97: Market opportunity By Geographical Landscape ($ million)
Exhibits98: Impact of drivers and challenges in 2022 and 2027
Exhibits99: Overview on Criticality of inputs and Factors of differentiation
Exhibits100: Overview on factors of disruption
Exhibits101: Impact of key risks on business
Exhibits102: Vendors covered
Exhibits103: Matrix on vendor position and classification
Exhibits104: Aspen Pharmacare Holdings - Overview
Exhibits105: Aspen Pharmacare Holdings - Business segments
Exhibits106: Aspen Pharmacare Holdings - Key offerings
Exhibits107: Aspen Pharmacare Holdings - Segment focus
Exhibits108: B. Braun SE - Overview
Exhibits109: B. Braun SE - Business segments
Exhibits110: B. Braun SE - Key news
Exhibits111: B. Braun SE - Key offerings
Exhibits112: B. Braun SE - Segment focus
Exhibits113: Baxter International Inc. - Overview
Exhibits114: Baxter International Inc. - Business segments
Exhibits115: Baxter International Inc. - Key news
Exhibits116: Baxter International Inc. - Key offerings
Exhibits117: Baxter International Inc. - Segment focus
Exhibits118: Eisai Co. Ltd. - Overview
Exhibits119: Eisai Co. Ltd. - Business segments
Exhibits120: Eisai Co. Ltd. - Key offerings
Exhibits121: Eisai Co. Ltd. - Segment focus
Exhibits122: Fresenius SE and Co. KGaA - Overview
Exhibits123: Fresenius SE and Co. KGaA - Business segments
Exhibits124: Fresenius SE and Co. KGaA - Key news
Exhibits125: Fresenius SE and Co. KGaA - Key offerings
Exhibits126: Fresenius SE and Co. KGaA - Segment focus
Exhibits127: Hikma Pharmaceuticals Plc - Overview
Exhibits128: Hikma Pharmaceuticals Plc - Business segments
Exhibits129: Hikma Pharmaceuticals Plc - Key offerings
Exhibits130: Hikma Pharmaceuticals Plc - Segment focus
Exhibits131: Laboratorios Farmaceuticos Rovi - Overview
Exhibits132: Laboratorios Farmaceuticos Rovi - Business segments
Exhibits133: Laboratorios Farmaceuticos Rovi - Key offerings
Exhibits134: Laboratorios Farmaceuticos Rovi - Segment focus
Exhibits135: Nanjing Kingfriend Biochemical - Overview
Exhibits136: Nanjing Kingfriend Biochemical - Product / Service
Exhibits137: Nanjing Kingfriend Biochemical - Key offerings
Exhibits138: Nichi Iko Pharmaceutical Co. Ltd. - Overview
Exhibits139: Nichi Iko Pharmaceutical Co. Ltd. - Product / Service
Exhibits140: Nichi Iko Pharmaceutical Co. Ltd. - Key offerings
Exhibits141: Novartis AG - Overview
Exhibits142: Novartis AG - Business segments
Exhibits143: Novartis AG - Key offerings
Exhibits144: Novartis AG - Segment focus
Exhibits145: Pfizer Inc. - Overview
Exhibits146: Pfizer Inc. - Product / Service
Exhibits147: Pfizer Inc. - Key news
Exhibits148: Pfizer Inc. - Key offerings
Exhibits149: Sanofi SA - Overview
Exhibits150: Sanofi SA - Business segments
Exhibits151: Sanofi SA - Key news
Exhibits152: Sanofi SA - Key offerings
Exhibits153: Sanofi SA - Segment focus
Exhibits154: Shenzhen Techdow Pharmaceutical - Overview
Exhibits155: Shenzhen Techdow Pharmaceutical - Product / Service
Exhibits156: Shenzhen Techdow Pharmaceutical - Key offerings
Exhibits157: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits158: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits159: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits160: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits161: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits162: Viatris Inc. - Overview
Exhibits163: Viatris Inc. - Business segments
Exhibits164: Viatris Inc. - Key offerings
Exhibits165: Viatris Inc. - Segment focus
Exhibits166: Inclusions checklist
Exhibits167: Exclusions checklist
Exhibits168: Currency conversion rates for US$
Exhibits169: Research methodology
Exhibits170: Validation techniques employed for market sizing
Exhibits171: Information sources
Exhibits172: List of abbreviations